Indication
Decrease of intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
Loading your page…
Loading your page…
Glaucoma, Open-Angle;Ocular Hypertension
Marketing Authorisation Holder: Novartis Europharm Limited
EMA Authorisation: 25/11/2008
INN: brinzolamide;timolol
AI Drug & Interaction Analysis
Free account required
Ask Osler about Azarga: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.